BBVLX | VIVAX | BBVLX / VIVAX | |
Total Expense Ratio | 0.24 | 0.17 | 141% |
Annual Report Gross Expense Ratio | 0.46 | 0.17 | 271% |
Fund Existence | 10 years | 33 years | - |
Gain YTD | 3.099 | 4.634 | 67% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 24.1B | 195B | 12% |
Annual Yield % from dividends | 1.86 | 2.06 | 91% |
Returns for 1 year | 0.34 | 6.60 | 5% |
Returns for 3 years | 16.82 | 29.52 | 57% |
Returns for 5 years | 57.49 | 71.83 | 80% |
Returns for 10 years | 110.18 | 112.08 | 98% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
VCEB | 63.37 | 0.48 | +0.76% |
Vanguard ESG US Corporate Bond ETF | |||
PBE | 65.54 | 0.24 | +0.37% |
Invesco Biotechnology & Genome ETF | |||
VNQ | 88.92 | -0.22 | -0.25% |
Vanguard Real Estate ETF | |||
RSEE | 30.11 | -0.48 | -1.55% |
Rareview Systematic Equity ETF | |||
XXCH | 26.11 | -0.69 | -2.58% |
Direxion Daily MSCI Em Mkt Ex Chn Bl 2X |